Anti-anginal Drugs Flashcards
Stable Angina
Exertional Angina
Pre-existing coronary artery occlusion.
Very predictable onset
Pain associated with physical exertion, cold stress, emotional stress
Treat by decrease O2 demand and increase O2 supply
Vasospastic Angina
Caused by unpredictable, transient vasospasm of the coronary vessels.
May develop at rest
Treat by decreasing vasospasm, reduce O2 demand
Unstable Angina
Caused by recurrent episodes of platelet clots at the site of the plaque
May be associated with MI
Treat by: Inhibit platelet aggregation, decrease O2 demand, Increase O2 supply, inhibit vasospasm
Treatment of Angina
Typically directed toward reducing O2 demand
Decrease Ventricular wall stress, cardiac contractility, and heart rate.
Nitrovasodilators
Gylceryl Trinitrate: sublingual, buccal, transdermal
Isosorbide Mononitrate: Sustained release, sublingual
Isosorbide Dintrate: Sustained Release formulation, sublingual
Nitrovasodilators Mechanism
Vasodilation reduces preload, which will reduce ventricular wall stress and myocardial O2 demand.
NO inhibits platelet aggregation which will help with unstable angina
Calcium Channel Blockers
Block L-type “slow” Calcium Channels.
Reduce Influx of Ca++ into vascular muscle
Preferential arteriolar vasodilators vs veins
Reduces Afterload and strain on heart
Beta Blockers
Reduce Heart Rate, Contractility, and Afterload (in hypertensive patients)
These three components reduce O2 demand
Ranolazine
Anti-Anginal effects independent of reductions in BP and/or HR
Useful as adjunct or alternative therapy
For chronic angina, not acute
Ranolazine
Anti-Anginal effects independent of reductions in BP and/or HR
Useful as adjunct or alternative therapy
For chronic angina, not acute